Solvay Pharmaceuticals Inc. sales and marketing update

Solvay withdrew from the U.S. market its Luvox fluvoxamine tablets to treat obsessive compulsive disorder. The company said the withdrawal is not due to concerns over safety or efficacy of the compoun...